What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort?
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
This Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. It explores vaccine intentions, information gaps, vaccine brand preferences, and tests a variety of potential incentives, messages, and pieces of information that might be used to increase vaccination uptake.
This issue brief explains the legal basis for vaccine mandates by the federal government, states, and private employers; highlights considerations for mandates while the COVID-19 vaccine is under an EUA; and discusses mandate exemptions based on disability or religious objection.
Of the 19 million U.S. children under 5, half are children of color, making this group more diverse than the U.S. population overall. There is also significant variation across the country.
To better understand the extent to which states have adopted policies consistent with CDC guidance, we examined state policies for all 50 states and DC focused on COVID-19 prevention strategies in K-12 public schools for the 2021-2022 school year.
Adults who report having ever been told by a doctor they have a weakened or compromised immune system are more likely than others to say they are worried about serious COVID-19 illness, with many reporting continued mask wearing and other precautions as mask mandates and other pandemic-relate restrictions are lifted.
We reviewed the websites and other official state sources for all 50 states and D.C. to see which are providing data on COVID-19 breakthrough cases, hospitalizations and deaths, how regularly, and what those data may tell us.
This analysis examines monkeypox (MPX) cases and vaccinations by race/ethnicity based on national data obtained from the Centers for Disease Control and Prevention (CDC). We find that while the current MPX outbreak in U.S. appears to be slowing down, disparities persist among Black and Hispanic people.
Just 7% of low-income countries' populations have received at least one dose of a COVID-19 vaccine as of December 20, well behind the 40% target for 2021.
Twenty-seven states have joined lawsuits challenging at least one aspect of the Biden administration’s vaccination requirements, but the vast majority are part of multiple lawsuits.
© 2026 KFF